BioLife Common Stock Total Equity vs Non Current Assets Total Analysis

BLFS Stock

USD 21.96 0.01 0.05%

BioLife Solutions financial indicator trend analysis is way more than just evaluating BioLife Solutions prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioLife Solutions is a good investment. Please check the relationship between BioLife Solutions Common Stock Total Equity and its Non Current Assets Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Common Stock Total Equity vs Non Current Assets Total

Common Stock Total Equity vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioLife Solutions Common Stock Total Equity account and Non Current Assets Total. At this time, the significance of the direction appears to have almost no relationship.

The correlation between BioLife Solutions' Common Stock Total Equity and Non Current Assets Total is 0.18. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of BioLife Solutions, assuming nothing else is changed. The correlation between historical values of BioLife Solutions' Common Stock Total Equity and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of BioLife Solutions are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Common Stock Total Equity i.e., BioLife Solutions' Common Stock Total Equity and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.18

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from BioLife Solutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 753.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 52.9 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	68.1M	93.7M	99.1M	104.1M
Cost Of Revenue	81.4M	107.9M	101.7M	106.8M

Total Operating Expenses Cost Of Revenue

BioLife Solutions fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Non Current Liabilities Total	Inventory	Net Receivables	Short Long Term Debt Total	Common Stock Total Equity	Short Term Investments	Short Term Debt
Total Assets		0.97	0.98	0.59	0.99	-0.15	-0.79	0.68	0.99	0.7	0.97	0.85	0.95	0.64	0.77	0.96	0.99	0.96	0.93	0.89	0.93	0.94	0.28	0.18	0.61	0.67
Other Current Liab	0.97		1.0	0.53	0.98	0.03	-0.91	0.57	0.96	0.55	0.99	0.79	0.96	0.48	0.77	0.98	0.99	0.94	0.87	0.92	0.99	0.94	0.33	0.19	0.7	0.8
Total Current Liabilities	0.98	1.0		0.52	0.99	0.02	-0.88	0.57	0.97	0.6	0.99	0.79	0.96	0.51	0.76	0.99	1.0	0.94	0.9	0.93	0.98	0.95	0.32	0.19	0.7	0.78
Total Stockholder Equity	0.59	0.53	0.52		0.51	-0.46	-0.38	0.68	0.61	0.16	0.58	0.52	0.55	0.3	0.93	0.46	0.51	0.53	0.34	0.37	0.55	0.3	0.1	0.1	-0.19	0.49
Property Plant And Equipment Net	0.99	0.98	0.99	0.51		-0.09	-0.83	0.65	0.98	0.69	0.97	0.85	0.96	0.62	0.73	0.98	1.0	0.97	0.93	0.92	0.94	0.96	0.3	0.19	0.69	0.7
Net Debt	-0.15	0.03	0.02	-0.46	-0.09		-0.23	-0.8	-0.1	-0.3	0.02	-0.54	-0.11	-0.69	-0.26	0.09	-0.02	-0.27	-0.04	0.17	0.09	0.06	0.09	0.13	0.3	0.31
Retained Earnings	-0.79	-0.91	-0.88	-0.38	-0.83	-0.23		-0.35	-0.76	-0.25	-0.87	-0.61	-0.9	-0.18	-0.7	-0.87	-0.86	-0.8	-0.64	-0.81	-0.95	-0.79	-0.34	-0.15	-0.75	-0.9
Cash	0.68	0.57	0.57	0.68	0.65	-0.8	-0.35		0.63	0.55	0.57	0.92	0.65	0.85	0.66	0.52	0.6	0.78	0.53	0.45	0.5	0.5	0.1	0.08	0.16	0.24
Non Current Assets Total	0.99	0.96	0.97	0.61	0.98	-0.1	-0.76	0.63		0.7	0.97	0.8	0.93	0.6	0.77	0.95	0.98	0.93	0.94	0.89	0.92	0.93	0.28	0.18	0.57	0.67
Non Currrent Assets Other	0.7	0.55	0.6	0.16	0.69	-0.3	-0.25	0.55	0.7		0.54	0.67	0.57	0.85	0.22	0.6	0.65	0.66	0.86	0.57	0.45	0.75	0.08	0.09	0.47	0.02
Other Assets	0.97	0.99	0.99	0.58	0.97	0.02	-0.87	0.57	0.97	0.54		0.77	0.94	0.46	0.8	0.98	0.98	0.92	0.87	0.92	0.97	0.92	0.33	0.2	0.63	0.81
Cash And Short Term Investments	0.85	0.79	0.79	0.52	0.85	-0.54	-0.61	0.92	0.8	0.67	0.77		0.84	0.86	0.65	0.76	0.82	0.95	0.75	0.69	0.72	0.77	0.21	0.12	0.53	0.43
Common Stock Shares Outstanding	0.95	0.96	0.96	0.55	0.96	-0.11	-0.9	0.65	0.93	0.57	0.94	0.84		0.55	0.79	0.92	0.96	0.96	0.84	0.82	0.96	0.9	0.29	0.08	0.69	0.74
Other Current Assets	0.64	0.48	0.51	0.3	0.62	-0.69	-0.18	0.85	0.6	0.85	0.46	0.86	0.55		0.3	0.49	0.56	0.71	0.69	0.45	0.36	0.6	0.07	0.04	0.33	-0.03
Other Stockholder Equity	0.77	0.77	0.76	0.93	0.73	-0.26	-0.7	0.66	0.77	0.22	0.8	0.65	0.79	0.3		0.7	0.74	0.73	0.52	0.61	0.81	0.55	0.21	0.14	0.16	0.75
Total Liab	0.96	0.98	0.99	0.46	0.98	0.09	-0.87	0.52	0.95	0.6	0.98	0.76	0.92	0.49	0.7		0.98	0.92	0.9	0.98	0.95	0.95	0.3	0.28	0.71	0.79
Property Plant And Equipment Gross	0.99	0.99	1.0	0.51	1.0	-0.02	-0.86	0.6	0.98	0.65	0.98	0.82	0.96	0.56	0.74	0.98		0.96	0.92	0.93	0.96	0.96	0.32	0.19	0.71	0.74
Total Current Assets	0.96	0.94	0.94	0.53	0.97	-0.27	-0.8	0.78	0.93	0.66	0.92	0.95	0.96	0.71	0.73	0.92	0.96		0.86	0.85	0.9	0.91	0.28	0.16	0.67	0.64
Accounts Payable	0.93	0.87	0.9	0.34	0.93	-0.04	-0.64	0.53	0.94	0.86	0.87	0.75	0.84	0.69	0.52	0.9	0.92	0.86		0.86	0.8	0.96	0.24	0.14	0.67	0.48
Non Current Liabilities Total	0.89	0.92	0.93	0.37	0.92	0.17	-0.81	0.45	0.89	0.57	0.92	0.69	0.82	0.45	0.61	0.98	0.93	0.85	0.86		0.88	0.9	0.27	0.37	0.68	0.77
Inventory	0.93	0.99	0.98	0.55	0.94	0.09	-0.95	0.5	0.92	0.45	0.97	0.72	0.96	0.36	0.81	0.95	0.96	0.9	0.8	0.88		0.89	0.31	0.18	0.69	0.85
Net Receivables	0.94	0.94	0.95	0.3	0.96	0.06	-0.79	0.5	0.93	0.75	0.92	0.77	0.9	0.6	0.55	0.95	0.96	0.91	0.96	0.9	0.89		0.28	0.15	0.8	0.6
Short Long Term Debt Total	0.28	0.33	0.32	0.1	0.3	0.09	-0.34	0.1	0.28	0.08	0.33	0.21	0.29	0.07	0.21	0.3	0.32	0.28	0.24	0.27	0.31	0.28		-0.07	0.39	0.41
Common Stock Total Equity	0.18	0.19	0.19	0.1	0.19	0.13	-0.15	0.08	0.18	0.09	0.2	0.12	0.08	0.04	0.14	0.28	0.19	0.16	0.14	0.37	0.18	0.15	-0.07		0.06	0.24
Short Term Investments	0.61	0.7	0.7	-0.19	0.69	0.3	-0.75	0.16	0.57	0.47	0.63	0.53	0.69	0.33	0.16	0.71	0.71	0.67	0.67	0.68	0.69	0.8	0.39	0.06		0.5
Short Term Debt	0.67	0.8	0.78	0.49	0.7	0.31	-0.9	0.24	0.67	0.02	0.81	0.43	0.74	-0.03	0.75	0.79	0.74	0.64	0.48	0.77	0.85	0.6	0.41	0.24	0.5

Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	93.0M	234.8M	552.6M	450.2M	412.7M	433.3M
Other Current Liab	3.5M	9.2M	20.4M	23.8M	24.6M	25.8M
Total Current Liabilities	7.8M	15.6M	40.0M	44.6M	42.2M	44.3M
Total Stockholder Equity	83.0M	205.2M	480.8M	(246.9M)	337.7M	354.5M
Property Plant And Equipment Net	6.6M	19.8M	36.8M	39.2M	32.6M	34.2M
Net Debt	(5.1M)	(79.3M)	(43.0M)	24.3M	7.3M	7.6M
Retained Earnings	(100.1M)	(97.4M)	(105.0M)	(246.9M)	(313.3M)	(297.7M)
Cash	6.4M	90.5M	69.9M	19.4M	35.4M	37.2M
Non Current Assets Total	68.8M	120.1M	426.7M	311.8M	292.1M	306.7M
Non Currrent Assets Other	3.9M	4.7M	9.8M	9.3M	273K	259.4K
Other Assets	50K	120.1M	426.7M	386.2M	444.1M	466.3M
Cash And Short Term Investments	6.4M	90.5M	69.9M	64.1M	51.7M	54.3M
Common Stock Shares Outstanding	19.5M	27.3M	38.5M	42.5M	43.7M	45.9M
Liabilities And Stockholders Equity	93.0M	234.8M	552.6M	(160.9M)	412.7M	433.3M
Other Current Assets	13.1M	103.1M	97.5M	74.4M	6.8M	11.7M
Other Stockholder Equity	183.1M	302.6M	586.0M	636K	651.3M	683.9M
Total Liab	10.0M	29.6M	71.9M	86.0M	75.1M	78.8M
Property Plant And Equipment Gross	6.6M	19.8M	43.5M	48.4M	42.1M	44.2M
Total Current Assets	24.2M	114.7M	125.9M	138.5M	120.6M	126.6M
Accounts Payable	3.1M	3.7M	14.9M	15.4M	6.9M	7.3M
Non Current Liabilities Total	2.2M	14.0M	31.9M	41.5M	32.9M	34.5M
Inventory	11.1M	11.6M	28.3M	34.9M	43.5M	45.6M
Net Receivables	5.3M	8.0M	23.2M	33.9M	18.7M	19.6M
Common Stock Total Equity	14.0K	19K	21K	33K	38.0K	35.1K
Common Stock	21K	33K	42K	43K	45K	36.6K
Property Plant Equipment	1.3M	5.6M	24.5M	46.6M	53.6M	56.3M
Other Liab	41.1M	14.0M	31.9M	2.6M	3.0M	2.8M
Net Tangible Assets	(12.2M)	205.2M	480.8M	364.2M	418.8M	439.8M
Retained Earnings Total Equity	(74.0M)	(71.0M)	(100.1M)	(97.4M)	(87.6M)	(92.0M)
Capital Surpluse	84.0M	114.2M	143.5M	302.6M	348.0M	365.4M

Pair Trading with BioLife Solutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLife Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Solutions will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioLife Stock

0.78

Guardant Health

Pair Corr

Moving against BioLife Stock

0.6	VREX	Varex Imaging Corp Potential Growth	Pair Corr
0.45	DH	Definitive Healthcare	Pair Corr
0.45	MD	Mednax Inc	Pair Corr

The ability to find closely correlated positions to BioLife Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLife Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLife Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLife Solutions to buy it.

The correlation of BioLife Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLife Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLife Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BioLife Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether BioLife Solutions is a strong investment it is important to analyze BioLife Solutions' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BioLife Solutions' future performance. For an informed investment choice regarding BioLife Stock, refer to the following important reports:

How To Invest In BioLife

Details

Is BioLife Stock a good investment?

Details

What is BioLife Solutions' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Note that the BioLife Solutions information on this page should be used as a complementary analysis to other BioLife Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for BioLife Stock analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Insider Screener Find insiders across different sectors to evaluate their impact on performance

Is BioLife Solutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

6.4

Earnings Share

(1.42)

Revenue Per Share

3.098

Quarterly Revenue Growth

(0.16)

Return On Assets

(0.08)

The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioLife Common Stock Total Equity vs Non Current Assets Total Analysis

Common Stock Total Equity vs Non Current Assets Total

Common Stock Total Equity vs Non Current Assets Total Correlation Analysis

Correlation Coefficient

Common Stock Total Equity

Non Current Assets Total

BioLife Solutions fundamental ratios Correlations

BioLife Solutions Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioLife Solutions fundamental ratios Accounts

Pair Trading with BioLife Solutions

Moving together with BioLife Stock

Moving against BioLife Stock

Complementary Tools for BioLife Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Property Plant And Equipment Gross	+ 1.0	Total Current Liabilities
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Total Assets

Inventory	- 0.95	Retained Earnings
Retained Earnings	- 0.91	Other Current Liab
Short Term Debt	- 0.9	Retained Earnings
Common Stock Shares Outstanding	- 0.9	Retained Earnings
Retained Earnings	- 0.88	Total Current Liabilities
Total Liab	- 0.87	Retained Earnings